MNMD vs REGN: Which Stock is Better?

Side-by-side comparison of Mind Medicine (Mindmed) Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

MNMD

Mind Medicine (Mindmed) Inc

$16.78

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricMNMDREGNWinner
Market Cap$1.46B$77.77BREGN
P/E RatioN/A17.58REGN
EPS (TTM)$N/A$41.75REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%45.8%REGN

Analyze MNMD

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MNMD or REGN a better investment?

Comparing MNMD and REGN: Mind Medicine (Mindmed) Inc has a market cap of $1.46B while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MNMD and REGN?

MNMD (Mind Medicine (Mindmed) Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MNMD or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MNMD or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for MNMD.

Which company is more profitable: MNMD or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to 0.0% for MNMD.

Which is the larger company: MNMD or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $1.46B for MNMD.

Should I buy MNMD or REGN in 2026?

Both MNMD and REGN have investment merit. MNMD trades at $16.78 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MNMD and REGN stock?

Key differences: Market Cap ($1.46B vs $77.77B), P/E Ratio (N/A vs 17.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 45.8%).

Popular Stock Comparisons